Defining meaningful change in Alzheimer's disease trials: The donepezil experience

被引：30

作者：

McLendon, BM

Doraiswamy, PM

机构：

[1] Duke Univ, Med Ctr, Dept Pharm, Drug Informat Serv, Durham, NC 27710 USA

[2] Duke Univ, Med Ctr, Dept Psychiat, Clin Trials Unit, Durham, NC 27710 USA

来源：

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY | 1999年 / 12卷 / 01期

关键词：

D O I：

10.1177/089198879901200108

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Regulatory guidelines in the US and Europe generally require that a drug specifically indicated for treating Alzheimer's disease (AD) must demonstrate an effect upon the core manifestations of dementia. Progressive cognitive and functional losses are the cardinal features of AD. In the US, current guidelines require that new AD treatments show effectiveness on performance-based measures of cognition and on clinician-rated global assessments. Improvement in function is also emphasized in the European guidelines. The primary instruments that have been used to evaluate changes in cognition and global function in most recent AD trials are the cognitive subscale of the Alzheimer's Disease Assessment Scale and a version of the Clinician's Interview Based Impression of Change, respectively. The results from three pivotal trials investigating the acetylcholinesterase inhibitor, donepezil, are used to demonstrate the way in which these tools are used, how to interpret the data they provide, and to determine their overall value in ascertaining efficacy in clinical practice.

引用

页码：39 / 48

页数：10

共 45 条

[11] MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].

FOLSTEIN, MF ;

FOLSTEIN, SE ;

MCHUGH, PR .

JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198

[12]

FRIEDHOFF LT, 1998, 21 CINP C JUL 12 16

[13] CLINICAL-NEUROPATHOLOGICAL CORRELATIONS IN ALZHEIMERS-DISEASE AND RELATED DEMENTIAS [J].

GALASKO, D ;

HANSEN, LA ;

KATZMAN, R ;

WIEDERHOLT, W ;

MASLIAH, E ;

TERRY, R ;

HILL, R ;

LESSIN, P ;

THAL, LJ .

ARCHIVES OF NEUROLOGY, 1994, 51 (09) :888-895

[14]

GRACON S, 1996, ALZHEIMER DIS MOL BI, P205

[15] A NEW CLINICAL-SCALE FOR THE STAGING OF DEMENTIA [J].

HUGHES, CP ;

BERG, L ;

DANZIGER, WL ;

COBEN, LA ;

MARTIN, RL .

BRITISH JOURNAL OF PSYCHIATRY, 1982, 140 (JUN) :566-572

[16] A 30-WEEK RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE [J].

KNAPP, MJ ;

KNOPMAN, DS ;

SOLOMON, PR ;

PENDLEBURY, WW ;

DAVIS, CS ;

GRACON, SI ;

APTER, JT ;

LAZARUS, CN ;

BAKER, KE ;

BARNETT, M ;

BAUMEL, B ;

EISNER, LS ;

CASTELLS, B ;

BOLOURI, R ;

BENNETT, D ;

FORCHETTI, C ;

LEVIN, A ;

BLASS, JP ;

NOLAN, KA ;

GAINES, ER ;

RELKIN, N ;

BORISON, RL ;

DIAMOND, B ;

CELESIA, GG ;

ROSS, AP ;

DEXTER, J ;

DOODY, R ;

LIPSCOMB, L ;

KREITER, K ;

DUBOFF, EA ;

BLOCK, P ;

MARSHALL, D ;

WESTERGAARD, N ;

EARL, NL ;

WYNE, SV ;

HINMANSMITH, E ;

FARLOW, M ;

HENDRIE, HC ;

CARESS, JA ;

FARMER, M ;

HARPER, JE ;

FERGUSON, J ;

FOSTER, NL ;

BARBAS, NR ;

BLUEMLEIN, LA ;

GELB, DJ ;

BERENT, S ;

GIORDANI, B ;

GREENWALD, M ;

BERGMAN, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (13) :985-991

[17] Long-term tacrine (Cognex) treatment: Effects on nursing home placement and mortality [J].

Knopman, D ;

Schneider, L ;

Davis, K ;

Talwalker, S ;

Smith, F ;

Hoover, T ;

Gracon, S ;

Apter, JT ;

Barnett, M ;

Baumel, B ;

Eisner, LS ;

Bennett, D ;

Forchetti, C ;

Blass, JP ;

Borison, RL ;

Celesia, GG ;

Dexter, J ;

Doody, R ;

DuBoff, EA ;

Earl, NL ;

Farlow, M ;

Hendrie, HC ;

Farmer, M ;

Ferguson, J ;

Foster, NL ;

Greenwald, M ;

Groenendyk, A ;

Jurkowski, C ;

Katz, I ;

Prodner, CK ;

Knopman, DS ;

Margolin, RA ;

Morris, JC ;

Rubin, EH ;

Reyes, PF ;

Rymer, MM ;

Sadowsky, CH ;

Pawluczyk, S ;

Smith, WT ;

Solomon, PR ;

Pendlebury, WW ;

Taylor, J ;

Thein, SG ;

Tuttle, P ;

Tyndall, RJ .

NEUROLOGY, 1996, 47 (01) :166-177

[18] THE CLINICIAN INTERVIEW-BASED IMPRESSION (CIBI) - A CLINICIAN GLOBAL CHANGE RATING-SCALE IN ALZHEIMERS-DISEASE [J].

KNOPMAN, DS ;

KNAPP, MJ ;

GRACON, SI ;

DAVIS, CS .

NEUROLOGY, 1994, 44 (12) :2315-2321

[19]

KRAMERGINSBERG E, 1988, PSYCHOPHARMACOL BULL, V24, P458

[20]

LEBER P, 1990, FDA LETT SPONSORS RE

← 1 2 3 4 5 →